Therapeutic applications of TRAIL receptor agonists in cancer and beyond (2015)
- Authors:
- Autor USP: MENDES, JOAO GUSTAVO PESSINI AMARANTE - ICB
- Unidade: ICB
- DOI: 10.1016/j.pharmthera.2015.09.001
- Subjects: CITOCINAS; NEOPLASIAS; APOPTOSE
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Pharmacology & Therapeutics
- ISSN: 1879-016X
- Volume/Número/Paginação/Ano: v. 155, p. 117-131, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AMARANTE-MENDES, João Gustavo Pessini e GRIFFITH, Thomas S. Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & Therapeutics, v. 155, p. 117-131, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.pharmthera.2015.09.001. Acesso em: 23 fev. 2026. -
APA
Amarante-Mendes, J. G. P., & Griffith, T. S. (2015). Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & Therapeutics, 155, 117-131. doi:10.1016/j.pharmthera.2015.09.001 -
NLM
Amarante-Mendes JGP, Griffith TS. Therapeutic applications of TRAIL receptor agonists in cancer and beyond [Internet]. Pharmacology & Therapeutics. 2015 ; 155 117-131.[citado 2026 fev. 23 ] Available from: https://doi.org/10.1016/j.pharmthera.2015.09.001 -
Vancouver
Amarante-Mendes JGP, Griffith TS. Therapeutic applications of TRAIL receptor agonists in cancer and beyond [Internet]. Pharmacology & Therapeutics. 2015 ; 155 117-131.[citado 2026 fev. 23 ] Available from: https://doi.org/10.1016/j.pharmthera.2015.09.001 - Apoptosis: a programme of cell death or cell disposal?
- Human tumor-associated antigen prame overexpression is associated with chronic myeloid leukemia progression
- Endostatin-Bax: a novel fusion protein with enhanced antiangiogênic activity
- Apoptosis induced by manganese in hematopoietic cell lines
- Development and characterization of murine models of T lymphoma to investigate the impact of oncogene expression
- Overexpression of the anti-apoptotic genes mcl-1, bcl-w, bcl-xL and a1 is correlated with chronic myelogenous leukemia progression and resistance to gleevec
- Crosstalk between TCR activation and dexamethasone administration in NKT cells: similarities and differences to T lymphocytes
- Silenciamento do gene wasp na leucemia mielóide crônica: consequências na sobrevida dos pacientes e na resistencia à apoptose das células leucêmicas
- Activation of an apoptosis-like program during megakaryocitic and monocytic/macrophagic differentiation of hematopoietic cell lines
- Prostaglandin e2 and melatonin alter the expression of death receptor ligands in cd4+ t-cells
Informações sobre o DOI: 10.1016/j.pharmthera.2015.09.001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
